Henry James International Management Inc. Red Hill Biopharma Ltd. Transaction History

Henry James International Management Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$2.31 - $5.85 $173,430 - $439,206	-75,078 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$4.55 - $10.36 $50,209 - $114,322	11,035 Added 17.23%	75,078 $344,000
Q1 2021 Apr 19, 2021	BUY	$6.98 - $11.29 $447,020 - $723,045	64,043 New	64,043 $469,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $415M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Henry James International Management Inc., based on Form 13F filings with the SEC.

Stay updated on Henry James International Management Inc. with notifications on news.